Latest news
Palantir Q2 2026: Revenue Up 93%, US Commercial 149%, Stock Soars 30% — Buy Now? - TradingKeyTradingKey · Sat, 08 Aug 2026 13:58:21 GMTMetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan - The TribuneThe Tribune · Sat, 08 Aug 2026 04:43:44 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 11:00:39 GMTAmerican Airlines and Infinium announce commercial passenger flight powered by eSAF - American AirlinesAmerican Airlines · Thu, 06 Aug 2026 14:09:48 GMTEIA: US commercial crude stocks nudge higher, offset by SPR draw - Quantum Commodity IntelligenceQuantum Commodity Intelligence · Wed, 05 Aug 2026 15:30:12 GMTCizzle Biotechnology Begins US Commercial Launch Of Lung Cancer Blood Test - DirectorsTalk InterviewsDirectorsTalk Interviews · Wed, 05 Aug 2026 12:06:00 GMTPalantir stock jumps nearly 30% after 'otherworldly' quarter as US commercial business booms - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 16:55:42 GMTPalantir: The U.S. Commercial Business Is About To Take The Lead (NASDAQ:PLTR) - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 11:45:43 GMT